Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: results of the NEOMUN trial by Albrecht Stenzinger, Dirk Jäger, Michael Thomas, Hauke Winter, Helge Bischoff, Uwe Haberkorn, Felix Herth, Pornpimol Charoentong, Petros Christopoulos, Rajkumar Savai, Laura V Klotz, Raffaella Griffo, Martin E Eichhorn, Florian Eichhorn, Benedikt Niedermaier, Philip Baum, Michael Allgäuer, Marc A Schneider, Claus-Peter Heußel, Maria Paula Roberti, Inka Zoernig

Get full text